136 related articles for article (PubMed ID: 16620188)
1. Antioxidant vitamin supplements and markers of bone turnover in a community sample of nonsmoking women.
Pasco JA; Henry MJ; Wilkinson LK; Nicholson GC; Schneider HG; Kotowicz MA
J Womens Health (Larchmt); 2006 Apr; 15(3):295-300. PubMed ID: 16620188
[TBL] [Abstract][Full Text] [Related]
2. Smoking, antioxidant vitamins, and the risk of hip fracture.
Melhus H; Michaëlsson K; Holmberg L; Wolk A; Ljunghall S
J Bone Miner Res; 1999 Jan; 14(1):129-35. PubMed ID: 9893075
[TBL] [Abstract][Full Text] [Related]
3. Effects of vitamin E on bone turnover markers among US postmenopausal women.
Hamidi MS; Corey PN; Cheung AM
J Bone Miner Res; 2012 Jun; 27(6):1368-80. PubMed ID: 22308007
[TBL] [Abstract][Full Text] [Related]
4. Lipid profile and bone paradox: higher serum lipids are associated with higher bone mineral density in postmenopausal women.
Brownbill RA; Ilich JZ
J Womens Health (Larchmt); 2006 Apr; 15(3):261-70. PubMed ID: 16620185
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of simultaneous measurement of bone formation and bone resorption markers to assess bone turnover rate in postmenopausal women: an EPOLOS study.
Łukaszkiewicz J; Karczmarewicz E; Płudowski P; Jaworski M; Czerwiński E; Lewiński A; Marcinowska-Suchowierska E; Milewicz A; Spaczyński M; Lorenc RS;
Med Sci Monit; 2008 Dec; 14(12):PH65-70. PubMed ID: 19043376
[TBL] [Abstract][Full Text] [Related]
6. Beta-blockers reduce bone resorption marker in early postmenopausal women.
Pasco JA; Henry MJ; Nicholson GC; Schneider HG; Kotowicz MA
Ann Hum Biol; 2005; 32(6):738-45. PubMed ID: 16418047
[TBL] [Abstract][Full Text] [Related]
7. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
[TBL] [Abstract][Full Text] [Related]
8. [The interest of biochemical markers of bone turnover for monitoring treatment of postmenopausal osteoporosis].
Kalaï E; Bahlous A; Makdouli A; Sahli H; Klouz A; Lakhal M; Sellami S; Abdelmoula J
Tunis Med; 2008 Feb; 86(2):122-7. PubMed ID: 18444527
[TBL] [Abstract][Full Text] [Related]
9. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
[TBL] [Abstract][Full Text] [Related]
10. Effects of protein-rich supplementation and nandrolone on bone tissue after a hip fracture.
Tengstrand B; Cederholm T; Söderqvist A; Tidermark J
Clin Nutr; 2007 Aug; 26(4):460-5. PubMed ID: 17498850
[TBL] [Abstract][Full Text] [Related]
11. The association of dietary calcium, bone mineral density and biochemical bone turnover markers in rural Thai women.
Pongchaiyakul C; Kosulwat V; Charoenkiatkul S; Chailurkit LO; Rojroongwasinkul N; Rajatanavin R
J Med Assoc Thai; 2008 Mar; 91(3):295-302. PubMed ID: 18575280
[TBL] [Abstract][Full Text] [Related]
12. Effect of phylloquinone supplementation on biochemical markers of vitamin K status and bone turnover in postmenopausal women.
Bügel S; Sørensen AD; Hels O; Kristensen M; Vermeer C; Jakobsen J; Flynn A; Mølgaard C; Cashman KD
Br J Nutr; 2007 Feb; 97(2):373-80. PubMed ID: 17298708
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional study of bone turnover markers in healthy premenopausal women.
de Papp AE; Bone HG; Caulfield MP; Kagan R; Buinewicz A; Chen E; Rosenberg E; Reitz RE
Bone; 2007 May; 40(5):1222-30. PubMed ID: 17331821
[TBL] [Abstract][Full Text] [Related]
14. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
[TBL] [Abstract][Full Text] [Related]
15. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
Perez EA; Josse RG; Pritchard KI; Ingle JN; Martino S; Findlay BP; Shenkier TN; Tozer RG; Palmer MJ; Shepherd LE; Liu S; Tu D; Goss PE
J Clin Oncol; 2006 Aug; 24(22):3629-35. PubMed ID: 16822845
[TBL] [Abstract][Full Text] [Related]
16. Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss.
Choi HJ; Im JA; Kim SH
Maturitas; 2008 Jun; 60(2):170-6. PubMed ID: 18572334
[TBL] [Abstract][Full Text] [Related]
17. Effect of risedronate on biochemical marker of bone resorption in postmenopausal women with osteoporosis or osteopenia.
Dane C; Dane B; Cetin A; Erginbas M
Gynecol Endocrinol; 2008 Apr; 24(4):207-13. PubMed ID: 18382907
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
[TBL] [Abstract][Full Text] [Related]
19. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
20. Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone.
Zikan V; Stepan JJ
Bone; 2009 Apr; 44(4):634-8. PubMed ID: 19150421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
